Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BluSense Diagnostics

BluSense Diagnostics
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
9 INVESTORS
Description

Provider of next-generation POCT platform designed to diagnose infectious diseases. The company's platform is developing a consumer-oriented point-of-care blood testing device based on a nanotechnology biosensing method that can deliver results in a few minutes with a single drop of blood, enabling people to monitor, control and manage virus outbreaks better.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Laboratory Services (Healthcare)
Primary Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark

+45 39 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BluSense Diagnostics’s full profile, request a free trial.

BluSense Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Early Stage VC (Series B) 26-Apr-2018 Completed Generating Revenue
7. Grant 19-Dec-2017 00000 Completed Generating Revenue
6. Grant 01-Jan-2016 Completed Generating Revenue
5. Grant 01-Jan-2016 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jan-2015 Completed Generating Revenue
3. Grant 01-Jan-2015 Completed Generating Revenue
2. Grant 01-Jan-2014 Completed Generating Revenue
1. Grant 01-Jan-2013 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BluSense Diagnostics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Global Entrepreneurship Movement Government 000 0000 000000 0
Markedsmodningsfonden Venture Capital Minority 000 0000 000000 0
U.S. Agency for International Development Government 000 0000 000000 0
Eurostars Government 000 0000 000000 0
GoBeyond Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

BluSense Diagnostics Executive Team (3)

Name Title Board
Seat
Contact
Info
Filippo Bosco Ph.D Co-Founder & Chief Executive Officer
Robert Burger Ph.D Co-Founder & Chief Operating Officer
Marco Donolato Ph.D Co-Founder, President and Chief Scientific Officer